Towards Response guided ADAptive Radiotherapy for organ preserving treatment of intermediate risk rectal cancer: a phase I dose finding trial
- Conditions
- rectal cancerrectal carcinoma100179901001799110017998
- Registration Number
- NL-OMON51912
- Lead Sponsor
- niversitair Medisch Centrum Utrecht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 45
Inclusion Criteria
primary intermediate risk rectal adenocarcinoma, fit for multimodal treatment
Exclusion Criteria
contra-indication for magnetic resonance-guided treatment or for pelvic
radiotherapy (such as inflammatory bowel disease, prior pelvic radiotherapy,
pregnancy, hip implants)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method